NY vs. CA vs. CO: How New York's Cannabis Market Stacks Up

If you've ever asked how New York's legal cannabis market compares to California or Colorado, the honest answer is this: New York is newer, smaller in footprint, and still finding its footing — but the quality ceiling here is already matching and, in some categories, surpassing what either of those states has built over the past decade. We launched Silly Nice in March 2024, built on Brooklyn grit, 25 years of partnership between co-founders Shane Breen and LeVar Thomas, and a belief that New Yorkers deserve access to the most precisely crafted, lab-verified cannabis products on the market. We chose New York not in spite of the challenge, but because of it.

California legalized adult-use cannabis in 2016. Colorado did it in 2012. New York didn't open its adult-use market until 2022, and licensed dispensaries didn't hit meaningful density until 2023 and 2024. On paper, we're behind. But markets that mature more slowly often demand higher standards from day one — and that's exactly what the New York Office of Cannabis Management has pushed for. For brands like us, that rigor isn't a burden. It's a competitive advantage we wear proudly.

Why We Planted Our Flag in New York

Shane is a U.S. Army Veteran. LeVar and Shane have built and maintained a partnership for over 25 years. When we decided to launch a cannabis brand, we didn't look west. We looked at our community — New Yorkers from the Bronx to Buffalo, from Crown Heights to Clinton Hill, from Harlem to Hollis — and we saw people who had been underserved by the legacy market, who deserved transparency, potency, and product integrity. That's what Silly Nice was built to deliver. We are Black-owned, Veteran-owned, LGBTQ+-owned, and family-run. Every batch we produce carries the weight of that identity.

California built the modern cannabis industry as we know it. The culture, the brands, the terminology — from live resin to solventless to single-source — much of that language was refined and exported from the Bay Area and Southern California dispensaries. The sheer scale of California's market is staggering: over 1,000 licensed retailers at peak, billions in annual sales, and decades of cultivator expertise baked into the soil of Humboldt, Mendocino, and Trinity counties. We have genuine respect for what California built.

But California's market also came with real problems. Oversaturation drove prices down and quality inconsistency up. The illicit market in California remains massive — accounting for an estimated two-thirds of all cannabis sales in the state — which means even legal consumers often can't tell if they're buying rigorously tested product or not. Branding became so dominant in California that it sometimes replaced substance. You could buy a beautifully packaged product with mediocre lab numbers and pay a premium for the aesthetic alone.

What New York Does Better Than California Right Now

New York's regulatory framework demands independent lab testing and Certificate of Analysis transparency at a level that California has struggled to enforce uniformly. Every product we sell — from our Diamond Powder at $50 per gram (86.24% THC, 98.54% total cannabinoids) to our Bubble Hash at $44 (53.32% THC, 6.2% terpene content) — has a COA you can pull up right now at sillynice.com/menu. That's not marketing. That's accountability. In New York, we earn trust with data, not just design.

Colorado was the first state in the nation to open legal adult-use dispensaries, doing so on January 1, 2014. For years, Denver was the cannabis tourism capital of America — a place where adults 21 and over could walk into a shop, browse an educated menu, and leave with legal flower, edibles, or concentrates purchased from regulated businesses. Colorado set the regulatory template that most states, including New York, have learned from. The seed-to-sale tracking, the potency testing requirements, the packaging rules — Colorado pioneered nearly all of it.

What Colorado didn't fully anticipate was market fatigue. After more than a decade of legal sales, Colorado's cannabis revenue has been declining year over year since 2021. Consumer novelty wore off, competition intensified, and many smaller craft producers got squeezed out by consolidation. The state that blazed the trail is now grappling with what sustainability looks like in a mature, commoditized market. That's a cautionary tale New York is watching closely.

The Craft Market Lesson Colorado Taught Us

Colorado showed the cannabis industry that small-batch, craft-forward producers can thrive — but only if they resist the race to the bottom on pricing and hold the line on quality. That's a lesson we took seriously at Silly Nice. Our Frosted Hash Ball, for example, is handmade — a 1-gram artisanal concentrate at $50, with 67.34% THC, 78.34% total cannabinoids, and a terpene content of 5.7%. It's not mass-produced. It's not cut with additives. It represents exactly the kind of craft intentionality that Colorado's best producers championed in their early years — and what we're bringing to New York right now.

New York has something neither California nor Colorado can replicate: the density, diversity, and discernment of New York City's consumer base, combined with a statewide population that spans upstate rural communities, mid-size cities like Rochester and Albany, and one of the most culturally influential metros on the planet. When a product earns shelf space at 150+ licensed dispensaries across this state — as Silly Nice has since our March 2024 launch — it has been vetted by some of the most sophisticated adult consumers in any cannabis market anywhere.

New York's market also launched with an explicit equity mission baked in. The Conditional Adult-Use Retail Dispensary (CAURD) program was designed to prioritize applicants with prior cannabis convictions — communities that bore the brunt of prohibition — giving them a first-mover advantage in legal retail. That's imperfect in execution, but the intention matters. As a Black-owned and Veteran-owned business, we know firsthand what it means when a market is designed to correct historical wrongs rather than just replicate existing power structures.

Potency, Pricing, and Product Quality in the NY Market

One of the most common questions we hear from adults who've shopped in California or Colorado is whether New York products can compete on quality and price. The answer, from where we stand, is yes — and in the concentrate category, we'd argue New York is already leading. Our 2G All-In-One vape in Alaskan Thunder Fuck comes in at $80 for two full grams, 82.46% THC, 84.06% total cannabinoids, rechargeable via USB-C. Our 510 Vape in Pink Stardust is $40 per gram at 81.96% THC with 100% cannabis-derived terpenes — no cutting agents, no synthetic flavor. Compare that to what you'd find in a California dispensary at equivalent potency, and New York holds its own.

We're not here to paint a perfect picture. New York's cannabis market has real challenges that California and Colorado worked through years ago and we're still navigating. Retail density remains thin in many parts of the state — there are neighborhoods in Queens, Staten Island, and upstate communities where licensed dispensaries are still hard to find, forcing consumers into the arms of unlicensed operators. That's a policy and enforcement problem, and it's one that ultimately hurts equity-focused brands like ours more than it hurts well-capitalized multi-state operators.

Banking access, licensing delays, and the ongoing presence of a robust illicit market are real friction points for New York cannabis businesses in 2024 and 2025. We've navigated all of it. As a small-batch, family-run operation, we don't have the luxury of absorbing losses that a venture-backed company might. What we have is the discipline that Shane's military background instilled, the long-view thinking that 25 years of partnership between our co-founders has built, and an unshakeable commitment to the New York community that chose us.

The Illicit Market Problem Is Real — And Legal Brands Pay the Price

California's gray market problem didn't appear overnight — it grew because early enforcement was inconsistent and consumer education lagged behind legalization. New York is at a crossroads on this same issue. Every adult consumer who buys from an unlicensed shop or a delivery service operating outside the regulatory framework is making a choice that, however understandable, weakens the legitimate market that equity operators like us depend on. We're not judging — we're asking our community to understand that the brands fighting hardest for New York are the ones operating in the light.

One of the clearest signs that New York's consumer palate is maturing fast is the reception our Infused Flower — Papaya Wine — has received since launch. At $60 for 3.5 grams, it comes in at 51.22% THC and 58.63% total cannabinoids, infused with live resin and THCa diamonds. This is not a beginner product. It's a product for adults who understand terpene profiles, who appreciate the difference between live resin and distillate, and who want something that delivers a full-spectrum experience rather than just raw potency numbers. That consumer exists in New York in abundance — and they're underserved by products that talk down to them.

California has had infused flower products for years, and Colorado's craft cultivators helped pioneer the category. But New York consumers are arriving to legal cannabis with years of legacy market experience behind them. They know what quality smells like. They know when terpenes are present and when they're not. They don't need to be educated on the basics — they need brands that meet them at their level. That's who we built Silly Nice for.

Terpene Content Is the Metric NY Consumers Are Starting to Ask About

For years, THC percentage was the only number most consumers cared about. California and Colorado both helped shift that conversation toward terpenes — and New York is accelerating that education fast. Our Bubble Hash carries 6.2% terpene content alongside its 53.32% THC. Our Frosted Hash Ball clocks 5.7% terpenes. Those numbers matter because terpenes drive the character of the experience — the way a product may help adults unwind, the aroma, the flavor, the overall quality of what you're consuming. Full lab data for every Silly Nice product is available at sillynice.com/menu. We publish it because we're proud of it.

California built the culture. Colorado built the regulatory template. New York is building something that neither of those states had the opportunity to build from the start: a legal cannabis market designed with equity, accountability, and community at its foundation. It's imperfect. It's slower than any of us would like. But it is ours — and as a Black-owned, Veteran-owned, LGBTQ+-owned, family-run brand operating in 150+ licensed dispensaries across this state, we are living proof that New York's cannabis market can produce world-class products with real community roots.

When New Yorkers choose Silly Nice — from a Harlem dispensary, a shop in Bed-Stuy, a licensed retailer in Astoria or the South Bronx or downtown Albany — they're not just buying a product. They're supporting an independent brand that did it the right way: small-batch, lab-verified, transparently priced, and built by people who have skin in the game and roots in this community. That's what California and Colorado built at their best. That's what we're building here, right now, in New York.

New York cannabis is for adults 21 and over. Every dispensary that carries Silly Nice is licensed, regulated, and committed to responsible retail. If you're looking for us, we're not hard to find — and we're not going anywhere.